Novel Treatments in Refractory Recurrent Pericarditis. [PDF]
Refractory recurrent pericarditis is a troublesome condition that severely impairs the quality of life of affected patients and significantly increases healthcare spending.
Lazarou E +7 more
europepmc +4 more sources
Use of Anakinra in steroid dependent recurrent pericarditis: a case report and review of literature
Non-steroidal anti-inflammatory drugs and colchicine are the cornerstone treatment for recurrent pericarditis. Corticosteroids are frequently used in patients with recurrent episodes of pericarditis.
Vinay Kumar Thallapally +3 more
doaj +2 more sources
Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial. [PDF]
Background Recurrent pericarditis may be mediated through inappropriate activation of the NACHT, leucine‐rich repeat, and pyrin domain‐containing protein 3 inflammasome. Pharmaceutically manufactured cannabidiol is an oral formulation that inhibits NACHT,
Luis SA +14 more
europepmc +2 more sources
Sex related differences in acute and recurrent pericarditis: A narrative review. [PDF]
Background: Acute and recurrent pericarditis represent significant clinical challenges, with growing evidence suggesting important sex-related differences in their presentation, etiology, and course.
Alanazi N.
europepmc +2 more sources
US Database Study of Clinical Burden and Unmet Need in Recurrent Pericarditis
Background Patients with recurrent pericarditis (RP) may develop complications, multiple recurrences, or inadequate treatment response. This study aimed to characterize disease burden and unmet needs in RP.
Mike Roy +2 more
exaly +3 more sources
Autoinflammatory Recurrent Pericarditis Associated with a New NLRP12 Mutation in a Male Adolescent [PDF]
Idiopathic recurrent pericarditis (IRP) can be the hallmark of an autoinflammatory syndrome with recurrent attacks of chest pain and symptom-free intervals following an acute episode. The recurrence rate may be 35% in the pediatric population, frequently
Cinteza E +6 more
europepmc +2 more sources
Comparative Efficacy and Safety of Colchicine and Anti-Interleukin-1 Agents in Recurrent Pericarditis: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials. [PDF]
Background The management of recurrent pericarditis includes colchicine and anti–interleukin‐1 agents, given the limited efficacy and adverse effects of NSAIDs and corticosteroids.
Ehsan M +8 more
europepmc +2 more sources
Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent Pericarditis. [PDF]
Recurrent pericarditis is a problematic clinical condition that impairs the quality of life of the affected patients due to the need for repeated hospital admissions, emergency department visits, and complications from medications, especially ...
Lazarou E +9 more
europepmc +2 more sources
Pericarditis as an onset of cancer
Pericarditis is an inflammation of the heart serous membrane of an infectious or non-infectious nature. Secondary pericardial effusion can be one of the few signs of cancer of the lung, pleura or breast in young people, while early treatment of the ...
D. F. Mesitskaya +4 more
doaj +1 more source
Background Recurrent pericarditis is characterized by painful flares and inflammation, which negatively impact health‐related quality of life. RHAPSODY (rilonacept inhibition of interleukin‐1 alpha and beta for recurrent pericarditis: a pivotal ...
Antonio Brucato +17 more
doaj +1 more source

